Collection of samples and data across the following diseases: Malignant tumour of ovary An international phase III randomised study to evaluate the efficacy of maintenance cediranib and olaparib combination therapy or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy
icon9 olaparib cediranib malignant tumour of ovary cancer ovarian